Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer

NCT00692289 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00692289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00692289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
July 31, 2010
Enrollment
1,510 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer